Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RECQL | P46063 | 1/20 | 0.53 |
| ▸ | LOX | P28300 | 1/20 | 0.53 |
| ▸ | LOXL3 | P58215 | 1/20 | 0.53 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | LPL | P06858 | 2/20 | 0.41 |
| ▸ | LIPG | Q9Y5X9 | 2/20 | 0.41 |
| ▸ | LNPEP | Q9UIQ6 | 1/20 | 0.40 |
| ▸ | ESR1 | P03372 | 2/20 | 0.40 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.40 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.40 |
| ▸ | TACR2 | P21452 | 2/20 | 0.40 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.40 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.40 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27672336 | 0.98 | RECQL (0.52) | RECQLLOXLOXL3LOXL2TDP1 | |
| SCHEMBL27878725 | 0.98 | RECQL (0.52) | RECQLLOXLOXL3LOXL2TDP1 | |
| SCHEMBL27902689 | 0.98 | RECQL (0.52) | RECQLLOXLOXL3LOXL2TDP1 | |
| SCHEMBL4438687 | 0.86 | RECQL (0.59) | RECQLLOXLOXL3LOXL2CYP3A4 | |
| SCHEMBL7455147 | 0.82 | RECQL (0.59) | RECQLLOXLOXL3LOXL2TDP1 | |
| SCHEMBL1328611 | 0.81 | LNPEP (0.48) | TDP1L3MBTL1PTGS2CYP3A4LPL | |
| Hydrochloric Acid SCHEMBL28861654 | 0.80 | LOX (0.61) | RECQLLOXLOXL3LOXL2GSK3A | |
| SCHEMBL24668667 | 0.79 | RECQL (0.55) | RECQLLOXLOXL3LOXL2TDP1 | |
| SCHEMBL11798255 | 0.79 | TDP1 (0.46) | TDP1L3MBTL1PTGS2CYP3A4LPL | |
| SCHEMBL16544526 | 0.79 | CYP3A4 (0.50) | TDP1L3MBTL1PTGS2CYP3A4LPL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115558196-A | Self-repairing anti-impact PP special material and preparation method thereof | 万华化学集团股份有限公司 | 2023-01-03 | — | — | CN | disclosed |
| CN-104600352-B | Sodium rechargeable battery with the graphite felt for forming air vent channel | SK INNOVATION CO.,LTD. (KR) | 2019-11-01 | — | — | CN | disclosed |
| CN-106457909-B | Tire | 株式会社普利司通 | 2018-12-07 | — | — | CN | disclosed |
| CN-104300153-B | Include the sodium rechargeable battery of graphite felt | SK新技术株式会社 | 2018-09-07 | — | — | CN | disclosed |
| CN-104078686-B | Current-collector for secondary cell and the secondary cell comprising it | SK新技术株式会社 | 2017-12-22 | — | — | CN | disclosed |
| CN-105188913-B | Method for regenerant ions compound | 信实工业公司 | 2017-09-19 | — | — | CN | disclosed |
| CN-106457909-A | Tire | 株式会社普利司通 | 2017-02-22 | — | — | CN | disclosed |
| CN-102498122-B | Biomass by hydrolyzation | 威斯康星校友研究基金会 | 2016-08-03 | — | — | CN | disclosed |
| CN-105188913-A | A process for regenerating ionic compound | RELIANCE IND LTD | 2015-12-23 | — | — | CN | disclosed |
| CN-102666665-B | Silicone compositions comprising a swollen silicone gel | DOW CORNING | 2015-07-22 | — | — | CN | disclosed |
| US-20090315454-A1 | IRIDIUM COMPLEX COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE OBTAINED BY USING THE SAME, AND USES OF THE DEVICE | SHOWA DENKO K.K. (JP) | 2009-12-24 | — | — | US | disclosed |
| CN-101535325-A | Iridium complex compound, organic electroluminescent device obtained using the same, and use of the device | SHOWA DENKO KK (JP) | 2009-09-16 | — | — | CN | disclosed |
| EP-2084171-A1 | IRIDIUM COMPLEX COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE OBTAINED BY USING THE SAME, AND USES OF THE DEVICE | Showa Denko K.K. (JP) | 2009-08-05 | — | — | EP | disclosed |
| WO-2008056799-A1 | IRIDIUM COMPLEX COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE OBTAINED BY USING THE SAME, AND USES OF THE DEVICE | SHOWA DENKO K.K. (JP) | 2008-05-15 | — | — | WO | disclosed |
| WO-2008056799-A1 | IRIDIUM COMPLEX COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE OBTAINED BY USING THE SAME, AND USES OF THE DEVICE | SHOWA DENKO K.K. (JP) | 2008-05-15 | — | — | WO | disclosed |
| EP-1572693-A1 | MITOGEN ACTIVATED PROTEIN KINASE-ACTIVATED PROTEIN KINASE-2 INHIBITING COMPOUNDS | Pharmacia Corporation (US) | 2005-09-14 | — | — | EP | disclosed |
| US-20040209897-A1 | Mitogen activated protein kinase-activated protein kinase-2 inhibiting compounds | PHARMACIA CORPORATION | 2004-10-21 | — | — | US | disclosed |
| WO-2004058762-A1 | MITOGEN ACTIVATED PROTEIN KINASE-ACTIVATED PROTEIN KINASE-2 INHIBITING COMPOUNDS | PHARMACIA CORPORATION (US) | 2004-07-15 | — | — | WO | disclosed |
| EP-1218360-A1 | TRIAZINE KINASE INHIBITORS | Amgen Inc., (US) | 2002-07-03 | — | — | EP | disclosed |
| WO-2001025220-A1 | TRIAZINE KINASE INHIBITORS | AMGEN INC. (US) | 2001-04-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090315454-A1 | IRIDIUM COMPLEX COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE OBTAINED BY USING THE SAME, AND USES OF THE DEVICE | ELP1, RUVBL1, LIG1 | RECQL 483/4885LOX 3021/4885LOXL3 1414/4885 |
| US-20040209897-A1 | Mitogen activated protein kinase-activated protein kinase-2 inhibiting compounds | MAPKAPK2, MAP3K2, MKNK2 | RECQL 3340/4885LOX 1332/4885LOXL3 3654/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.